Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A Multi-Center Study of BRCA1 and BRCA2 Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population.

Millan Catalan O, Campos-Parra AD, Vázquez-Romo R, Cantú de León D, Jacobo-Herrera N, Morales-González F, López-Camarillo C, Rodríguez-Dorantes M, López-Urrutia E, Pérez-Plasencia C.

Cancers (Basel). 2019 Aug 26;11(9). pii: E1246. doi: 10.3390/cancers11091246.

2.

miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.

Martinez-Gutierrez AD, Catalan OM, Vázquez-Romo R, Porras Reyes FI, Alvarado-Miranda A, Lara Medina F, Bargallo-Rocha JE, Orozco Moreno LT, Cantú De León D, Herrera LA, López-Camarillo C, Pérez-Plasencia C, Campos-Parra AD.

Int J Mol Med. 2019 Oct;44(4):1267-1280. doi: 10.3892/ijmm.2019.4292. Epub 2019 Jul 30.

3.

MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.

Pedroza-Torres A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, Zamudio-Meza H, Cantú de León D, Montalvo-Esquivel G, Isla-Ortiz D, Herrera LA, Ángeles-Zaragoza Ó, Robelo-Romero G, Herrera-Gómez Á, Pérez-Plasencia C.

Oncol Rep. 2018 Mar;39(3):1532-1540. doi: 10.3892/or.2018.6219. Epub 2018 Jan 18.

PMID:
29399698
4.

Comprehensive transcriptome analysis identifies pathways with therapeutic potential in locally advanced cervical cancer.

Campos-Parra AD, Padua-Bracho A, Pedroza-Torres A, Figueroa-González G, Fernández-Retana J, Millan-Catalan O, Peralta-Zaragoza O, Cantú de León D, Herrera LA, Pérez-Plasencia C.

Gynecol Oncol. 2016 Nov;143(2):406-413. doi: 10.1016/j.ygyno.2016.08.327. Epub 2016 Aug 28.

Supplemental Content

Loading ...
Support Center